These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15830288)

  • 41. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors.
    Numata K; Tanaka K; Kiba T; Morimoto M; Arata S; Kondo M; Sekihara H
    AJR Am J Roentgenol; 1997 Apr; 168(4):991-5. PubMed ID: 9124156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of portal hemodynamic investigation in prediction of hepatic functional reserve in patients with hepatocellular carcinoma undergoing operative treatment.
    Yin XY; Lu MD; Huang JF; Liang LJ
    Hepatogastroenterology; 2001; 48(42):1701-4. PubMed ID: 11813604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of ultrasonography in the diagnosis and treatment tracing of hepatocellular carcinoma-associated arteriovenous fistulas.
    Li YY; Duan YY; Yan GZ; Lv FQ; Cao W; Cao TS; Yuan LJ
    Liver Int; 2007 Aug; 27(6):869-75. PubMed ID: 17617131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study.
    Lopez-Ben R; Robbin ML; Weber TM; Smith JK; Needleman L; Berland LL
    J Ultrasound Med; 1999 Feb; 18(2):109-16. PubMed ID: 10206803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Power Doppler sonography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma.
    Spiezia S; Vallone P; Fiore F; Ricchi P; Daniele B; Picone G; Cerbone G; De Vivo R; Perrone F; Castiglione F; Pignata S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):548-53. PubMed ID: 9513831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
    Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
    Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
    Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
    AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma.
    Shin D; Kim TH; Park SY; Kwak J; Moon SH; Yoon M; Lee SB; Park S; Shin KH; Kim DY; Cho KH; Park JW; Kim CM
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):687-94. PubMed ID: 18448269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
    Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
    Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.
    Gaiani S; Celli N; Piscaglia F; Cecilioni L; Losinno F; Giangregorio F; Mancini M; Pini P; Fornari F; Bolondi L
    J Hepatol; 2004 Sep; 41(3):421-6. PubMed ID: 15336445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.
    Fujishima T; Yoshida H; Obi S; Shiina S; Kanda M; Tateishi R; Akamatsu M; Koike Y; Sato S; Teratani T; Kawabe T; Shiratori Y; Omata M
    J Gastroenterol; 2005 Mar; 40(3):266-73. PubMed ID: 15830286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment response.
    Kim EY; Choi D; Lim DH; Lee WJ; Yoo BC; Paik SW
    Eur J Radiol; 2009 Dec; 72(3):440-6. PubMed ID: 18819767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasound of focal hepatic lesions.
    Nisenbaum HL; Rowling SE
    Semin Roentgenol; 1995 Oct; 30(4):324-46. PubMed ID: 8539643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some unusual complications of malignancies: case 1. Spontaneous rupture of hepatocellular carcinoma demonstrated by contrast-enhanced sonography.
    Chou YH; Chiou HJ; Tiu CM; Chen JD; Hung GS; Chiang JH
    J Clin Oncol; 2002 Oct; 20(19):4108-11. PubMed ID: 12351607
    [No Abstract]   [Full Text] [Related]  

  • 59. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings.
    Kim SK; Lim HK; Kim YH; Lee WJ; Lee SJ; Kim SH; Lim JH; Kim SA
    Radiographics; 2003; 23(1):107-21. PubMed ID: 12533646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.